Caplin Point Laboratories (CAPLIPOINT.BO) Earnings Analysis
Caplin Point Laboratories (CAPLIPOINT.BO) next reports earnings on 2026-08-12. Trailing P/E 29.59.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CAPLIPOINT.BO next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 5.79B |
CAPLIPOINT.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | 22.9 INR | n/a | n/a | n/a |
| 2026-02-05 | 21.8 INR | n/a | n/a | n/a |
CAPLIPOINT.BO valuation and analyst view
| Trailing P/E | 29.59 |
|---|---|
| Trailing EPS | 84.363 INR |
| Price / book | 5.29 |
| Dividend yield | 0.28% |
| Market cap | 188.55B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Caplin Point Laboratories (CAPLIPOINT.BO)'s next earnings date?
Caplin Point Laboratories is next scheduled to report on 2026-08-12 and revenue estimate of 5.79B.
Did CAPLIPOINT.BO beat earnings last quarter?
Consensus estimate data was not available for CAPLIPOINT.BO's 2026-05-14 report.
What is CAPLIPOINT.BO's current P/E ratio and EPS?
CAPLIPOINT.BO trades at a trailing P/E of 29.59 on trailing EPS of 84.36258387054335 INR.
What do analysts rate CAPLIPOINT.BO?
CAPLIPOINT.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.